External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home ESOPRS 2026
Roche and Genentech at

ESOPRS 2026

September 10 - September 12
Cascais, Portugal
esoprs.eu
We will be contributing to topics related to
Ophthalmology
Add to calendar
Share feedback
Share page
-
Agenda
Medical Materials
03:40 PM
Duration 5mins Cascais, Portugal
Primary Results of the Phase 3 SatraGO-1 and SatraGO-2 Trials: Efficacy and Safety of Satralizumab in Thyroid Eye Disease
Santiago Ortiz-Perez
Ophthalmology | Thyroid eye disease

You have successfully signed up for this alert. You will be notified when it is available.

Notify me

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar
Coming soon

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.